Business Description
AdAlta Ltd
ISIN : AU0000001AD2
Description
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.83 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.83 | |||||
| Debt-to-EBITDA | -0.41 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.6 | |||||
| 3-Year EPS without NRI Growth Rate | 25.3 | |||||
| 3-Year FCF Growth Rate | 23 | |||||
| 3-Year Book Growth Rate | -39 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.46 | |||||
| 9-Day RSI | 35.26 | |||||
| 14-Day RSI | 39.79 | |||||
| 6-1 Month Momentum % | 38.1 | |||||
| 12-1 Month Momentum % | 23.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.83 | |||||
| Quick Ratio | 1.83 | |||||
| Cash Ratio | 1.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.6 | |||||
| Shareholder Yield % | -18.71 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -214.91 | |||||
| ROA % | -73.08 | |||||
| ROIC % | -242.81 | |||||
| ROC (Joel Greenblatt) % | -1712.24 | |||||
| ROCE % | -207.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.6 | |||||
| Price-to-Tangible-Book | 2.3 | |||||
| EV-to-EBIT | -2.16 | |||||
| EV-to-EBITDA | -2.17 | |||||
| EV-to-FCF | -1.69 | |||||
| Price-to-Net-Current-Asset-Value | 2.3 | |||||
| Earnings Yield (Greenblatt) % | -46.2 | |||||
| FCF Yield % | -50.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AdAlta Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.013 | ||
| Beta | 0.12 | ||
| Volatility % | 34.31 | ||
| 14-Day RSI | 39.79 | ||
| 14-Day ATR (A$) | 0.002073 | ||
| 20-Day SMA (A$) | 0.027225 | ||
| 12-1 Month Momentum % | 23.4 | ||
| 52-Week Range (A$) | 0.017 - 0.048 | ||
| Shares Outstanding (Mil) | 533.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AdAlta Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AdAlta Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
AdAlta Ltd Frequently Asked Questions
What is AdAlta Ltd(ASX:1AD)'s stock price today?
The current price of ASX:1AD is A$0.02. The 52 week high of ASX:1AD is A$0.05 and 52 week low is A$0.02.
When is next earnings date of AdAlta Ltd(ASX:1AD)?
The next earnings date of AdAlta Ltd(ASX:1AD) is .
Does AdAlta Ltd(ASX:1AD) pay dividends? If so, how much?
AdAlta Ltd(ASX:1AD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers